IL24 and neoplasm: These results support the hypothesis that in specific contexts and cell types, tumor suppression with mda-7/IL-24 can be promoted by a subset of cancerous cells producing and secreting MDA-7/IL-24 that suppress adjacent tumor cells, inhibiting survival and tumor development, i.e., “bystander” anti-cancer activity [75,76,77,82].